Cargando…

Anti-HCMV activity by an irreversible p97 inhibitor LC-1310

The AAA+ (ATPase associated with various cellular activities) protein p97, also called valosin-containing protein, is a hexameric ring ATPase and uses ATP hydrolysis to unfold or extract proteins from biological complexes. Many cellular processes are affected by p97 including ER-associated degradati...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yan, Soto-Acosta, Ruben, Ding, Rui, Chen, Liqiang, Geraghty, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794631/
https://www.ncbi.nlm.nih.gov/pubmed/33456290
http://dx.doi.org/10.1007/s00044-020-02679-1
_version_ 1783634255310487552
author Wang, Yan
Soto-Acosta, Ruben
Ding, Rui
Chen, Liqiang
Geraghty, Robert J.
author_facet Wang, Yan
Soto-Acosta, Ruben
Ding, Rui
Chen, Liqiang
Geraghty, Robert J.
author_sort Wang, Yan
collection PubMed
description The AAA+ (ATPase associated with various cellular activities) protein p97, also called valosin-containing protein, is a hexameric ring ATPase and uses ATP hydrolysis to unfold or extract proteins from biological complexes. Many cellular processes are affected by p97 including ER-associated degradation, DNA damage response, cell signaling (NF-κB), cell cycle progression, autophagy, and others. Not surprisingly, with its role in many fundamental cellular processes, p97 function is important for the replication of many viruses. We tested irreversible p97-targeting compounds for their ability to inhibit the replication of multiple viruses compared to the known p97 inhibitors NMS-873 and CB-5083. Our results indicate that overall cellular toxicity for p97 compounds provides a challenge for antivirals targeting p97. However, we identified one compound with sub-micromolar activity against human cytomegalovirus and improved cell viability to provide evidence for the potential of irreversible p97 inhibitors as antivirals. [Image: see text]
format Online
Article
Text
id pubmed-7794631
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-77946312021-01-11 Anti-HCMV activity by an irreversible p97 inhibitor LC-1310 Wang, Yan Soto-Acosta, Ruben Ding, Rui Chen, Liqiang Geraghty, Robert J. Med Chem Res Original Research The AAA+ (ATPase associated with various cellular activities) protein p97, also called valosin-containing protein, is a hexameric ring ATPase and uses ATP hydrolysis to unfold or extract proteins from biological complexes. Many cellular processes are affected by p97 including ER-associated degradation, DNA damage response, cell signaling (NF-κB), cell cycle progression, autophagy, and others. Not surprisingly, with its role in many fundamental cellular processes, p97 function is important for the replication of many viruses. We tested irreversible p97-targeting compounds for their ability to inhibit the replication of multiple viruses compared to the known p97 inhibitors NMS-873 and CB-5083. Our results indicate that overall cellular toxicity for p97 compounds provides a challenge for antivirals targeting p97. However, we identified one compound with sub-micromolar activity against human cytomegalovirus and improved cell viability to provide evidence for the potential of irreversible p97 inhibitors as antivirals. [Image: see text] Springer US 2021-01-09 2021 /pmc/articles/PMC7794631/ /pubmed/33456290 http://dx.doi.org/10.1007/s00044-020-02679-1 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Research
Wang, Yan
Soto-Acosta, Ruben
Ding, Rui
Chen, Liqiang
Geraghty, Robert J.
Anti-HCMV activity by an irreversible p97 inhibitor LC-1310
title Anti-HCMV activity by an irreversible p97 inhibitor LC-1310
title_full Anti-HCMV activity by an irreversible p97 inhibitor LC-1310
title_fullStr Anti-HCMV activity by an irreversible p97 inhibitor LC-1310
title_full_unstemmed Anti-HCMV activity by an irreversible p97 inhibitor LC-1310
title_short Anti-HCMV activity by an irreversible p97 inhibitor LC-1310
title_sort anti-hcmv activity by an irreversible p97 inhibitor lc-1310
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794631/
https://www.ncbi.nlm.nih.gov/pubmed/33456290
http://dx.doi.org/10.1007/s00044-020-02679-1
work_keys_str_mv AT wangyan antihcmvactivitybyanirreversiblep97inhibitorlc1310
AT sotoacostaruben antihcmvactivitybyanirreversiblep97inhibitorlc1310
AT dingrui antihcmvactivitybyanirreversiblep97inhibitorlc1310
AT chenliqiang antihcmvactivitybyanirreversiblep97inhibitorlc1310
AT geraghtyrobertj antihcmvactivitybyanirreversiblep97inhibitorlc1310